NOVEMBER 2022LIFE SCIENCES REVIEW6Clinical trial processes are transforming to encompass more decentralised activities and locations, which affects sponsors, sites, and research participants. Although there has been interest in some aspects of decentralisation for some time, biopharma has been reluctant to adopt new methods because of an underlying risk aversion. However, the COVID-19 outbreak served as a stimulus for businesses to reevaluate the risk-reward ratio for trial decentralisation components and has assisted in boosting openness and accelerating adoption.Additionally, businesses that are commercialising products must now conduct multichannel sales and marketing campaigns to reach their target customers. They must also comply with post-launch marketing regulatory obligations that are becoming more onerous. New developments in digitization, clinical trial implementation, globalisation, and integration are simultaneously changing how businesses conduct their R&D and go-to-market strategies. Together, these factors are leading the pharma services ecosystem to develop and mature, transforming how businesses succeed in the industry.This edition of Life Sciences Review features "Top 10 Pharma Consulting Companies in Europe - 2022," highlighting some of the key developments in the space and how companies are leveraging pharma consulting services to boost their growth. The magazine highlights companies like Ascenian, which provides an innovative platform steered by experts who deliver decision-planning solutions for seamless market access strategy of new drugs.The magazine features companies like IMAC that help pharmaceutical companies complete HTA submissions and win reimbursements by strategizing and creating HTA dossiers. Likewise, this edition also talks about companies like Solitek that bring a new concept in solid-state development services for the pharmaceutical, agrochemical, and fine chemical industries.Additionally, this magazine put forth thought leadership articles from Dr. Linda Randall, AVP Biologics Development, Manufacturing & Control at Pharmaron Gene Therap & Jesper Lekdorf, MD, Sr. Medical Director, Head of Medical Affairs, Novo Nordisk Japan, among others, who have imparted their opinions on how pharma consulting services can help businesses to attain further innovation and growth.Write to us about how you leverage pharma consulting services in your organizations!EDITORIALLeveraging Pharma Consulting Services to Boost GrowthCopyright © 2022 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.Editorial StaffAaron PierceCarolynn WaltersShirley FaithRussell ThomasGilbert HooverAncel CastelinoDisclaimer: *Some of the Insights are based on our interviews with CIOs and CXOsJeremy WilliamsManaging Editoreditor@lifesciencesreview.comManaging EditorJeremy WilliamsNovember - 18 - 2022, Vol 03, Issue - 10 (ISSN 2831-8323) Published by ValleyMedia, Inc.To subscribe to Life Sciences ReviewVisit www.lifesciencesreview.com VisualizersRonald DonovanVictor Cruz Email:sales@lifesciencesreview.comeditor@lifesciencesreview.commarketing@lifesciencesreview.com
< Page 5 | Page 7 >